insights_auto
Why is GRAL up 4,15%?
Dive Deeperchevron_right
GRAL:NASDAQ
Grail Inc
129,85 $
arrow_upward
+4,15%(+5,18) 1D
21 հոկ, 10:17:42 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GRAL...
Open
123,88 $
High
130,55 $
Low
123,20 $
Mkt. cap
5,80 մլրդ
Avg. vol.
1,34 մլն
Volume
53,96 հզր
52-wk high
166,48 $
52-wk low
41,50 $
EPS
-9,75 $
Shares outstanding
44,67 մլն
No. of employees
910
Open
123,88 $
High
130,55 $
Low
123,20 $
Mkt. cap
5,80 մլրդ
Avg. vol.
1,34 մլն
Volume
53,96 հզր
52-wk high
166,48 $
52-wk low
41,50 $
EPS
-9,75 $
Shares outstanding
44,67 մլն
No. of employees
910
News stories
From web sources and news partners
https://www.dars.gov.et/
·
5 օր առաջ
GRAIL (GRAL) Stock: Falls -1.00% — Where's the Floor? 2026-10-15 - Profit Surge Picks
Profile
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021, GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023, EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.
Joshua Ofman is CEO. Wikipedia
About Grail Inc
CEO-
Employees910
Founded2015
HeadquartersՄենլո պարկ, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitegrail.com